BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21253306)

  • 1. Sorafenib-induced interstitial pneumonitis in a patient with hepatocellular carcinoma: a case report.
    Myung HJ; Jeong SH; Kim JW; Kim HS; Jang JH; Yoon HI; Kim JS
    Gut Liver; 2010 Dec; 4(4):543-6. PubMed ID: 21253306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial pneumonia induced by sorafenib in a patient with hepatocellular carcinoma: An autopsy case report.
    Yamaguchi T; Seki T; Miyasaka C; Inokuchi R; Kawamura R; Sakaguchi Y; Murata M; Matsuzaki K; Nakano Y; Uemura Y; Okazaki K
    Oncol Lett; 2015 Apr; 9(4):1633-1636. PubMed ID: 25789013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique bleeding-related complication of sorafenib, a tyrosine kinase inhibitor, in advanced hepatocellular carcinoma: a case report.
    Kang HY; Moon SH; Song IH
    J Med Case Rep; 2014 Feb; 8():72. PubMed ID: 24571585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib: a review of its use in advanced hepatocellular carcinoma.
    Keating GM; Santoro A
    Drugs; 2009; 69(2):223-40. PubMed ID: 19228077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib-induced acute interstitial pneumonia in patients with advanced hepatocellular carcinoma: report of three cases.
    Takeda H; Nishikawa H; Iguchi E; Matsuda F; Kita R; Kimura T; Osaki Y
    Clin J Gastroenterol; 2012; 5(4):407-12. PubMed ID: 24672586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: a case report.
    Okuwaki Y; Nakazawa T; Hidaka H; Shibuya A; Koizumi W
    J Med Case Rep; 2012 Jan; 6():38. PubMed ID: 22280970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2-3 study.
    Ren Z; Xu J; Bai Y; Xu A; Cang S; Du C; Li Q; Lu Y; Chen Y; Guo Y; Chen Z; Liu B; Jia W; Wu J; Wang J; Shao G; Zhang B; Shan Y; Meng Z; Wu J; Gu S; Yang W; Liu C; Shi X; Gao Z; Yin T; Cui J; Huang M; Xing B; Mao Y; Teng G; Qin Y; Wang J; Xia F; Yin G; Yang Y; Chen M; Wang Y; Zhou H; Fan J;
    Lancet Oncol; 2021 Jul; 22(7):977-990. PubMed ID: 34143971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptional serological and radiological response to sorafenib in 2 patients with advanced hepatocellular carcinoma and chronic hepatitis C viral infection: case report and review of the literature.
    Atkin C; Earwaker P; Pallan A; Shetty S; Punia P; Ma YT
    BMC Gastroenterol; 2017 Feb; 17(1):30. PubMed ID: 28193171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature.
    Futsukaichi Y; Tajiri K; Kobayashi S; Nagata K; Yasumura S; Takahara T; Minemura M; Yasuda I
    Clin J Gastroenterol; 2019 Apr; 12(2):128-134. PubMed ID: 30374884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy.
    Kuroda D; Hayashi H; Nitta H; Imai K; Abe S; Hashimoto D; Chikamoto A; Ishiko T; Beppu T; Baba H
    Surg Case Rep; 2016 Dec; 2(1):4. PubMed ID: 26943680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
    Perboni G; Costa P; Fibbia GC; Morandini B; Scalzini A; Tagliani A; Cengarle R; Aitini E
    Oncologist; 2010; 15(2):142-5. PubMed ID: 20142333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complete response induced by 21-day sorafenib therapy in a patient with advanced hepatocellular carcinoma.
    Hagihara A; Teranishi Y; Kawamura E; Fujii H; Iwai S; Morikawa H; Enomoto M; Tamori A; Kawada N
    Intern Med; 2013; 52(14):1589-92. PubMed ID: 23857091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltrative hepatocellular carcinoma with multiple lung metastasis completely cured using nivolumab: a case report.
    Han JE; Cho HJ; Kim SS; Cheong JY
    J Liver Cancer; 2021 Sep; 21(2):169-176. PubMed ID: 37383079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
    Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
    Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma.
    Gerardi AM; Stoppino LP; Liso A; Macarini L; Landriscina M
    Oncol Lett; 2013 Mar; 5(3):975-977. PubMed ID: 23426789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma.
    Aihara Y; Yoshiji H; Yamazaki M; Ikenaka Y; Noguchi R; Morioka C; Kaji K; Tastumi H; Nakanishi K; Nakamura M; Yamao J; Toyohara M; Mitoro A; Sawai M; Yoshida M; Fujimoto M; Uemura M; Fukui H
    World J Gastrointest Oncol; 2012 May; 4(5):115-8. PubMed ID: 22645635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival with sorafenib-based multidisciplinary treatment for Vp4 hepatocellular carcinoma: a case report.
    Narita H; Kawaratani H; Shibamoto A; Takeda S; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Nishimura N; Hokuto D; Sho M; Yoshiji H
    Clin J Gastroenterol; 2022 Oct; 15(5):953-959. PubMed ID: 35773571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
    Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
    Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sustained Complete Response of Hepatocellular Carcinoma with Multiple Intrahepatic Metastases following the Discontinuation of Sorafenib].
    Takeda Y; Ohmura Y; Katsura Y; Sakamoto T; Nose Y; Mori R; Inatome J; Kawai K; Naito A; Murakami K; Kagawa Y; Masuzawa T; Takeno A; Egawa C; Murata K
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):532-536. PubMed ID: 30914605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.
    Nakamura K; Beppu T; Hayashi H; Okabe H; Imai K; Nitta H; Chikamoto A; Ishiko T; Sasaki M; Baba H
    Int Surg; 2015 May; 100(5):908-14. PubMed ID: 26011214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.